Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study

Autor: Gunnar Gislason, Lene Dreyer, Kristian Kofoed, Jeanette Halskou Haugaard, Alexander Egeberg, Mathias Bo Ottosen

Publikováno v: Haugaard, J H, Dreyer, L, Ottosen, M B, Gislason, G, Kofoed, K & Egeberg, A 2021, ' Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus : A Danish nationwide cohort study ', Journal of the American Academy of Dermatology, vol. 84, no. 4, pp. 930-937 . https://doi.org/10.1016/j.jaad.2020.12.013

BACKGROUND: Limited data suggest that hydroxychloroquine may affect risk of cardiovascular disease in patients with lupus erythematosus (LE).OBJECTIVE: To investigate whether hydroxychloroquine treatment is associated with major adverse cardiovascula

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3a480823f576cc8bb679d38023348f9
https://pubmed.ncbi.nlm.nih.gov/33321159